Albany Molecular Research Inc
AMRI
AMRI was delisted on the 31st of August, 2017.
131 hedge funds and large institutions have $571M invested in Albany Molecular Research Inc in 2015 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 51 increasing their positions, 33 reducing their positions, and 20 closing their positions.
125% more call options, than puts
Call options by funds: $3.33M | Put options by funds: $1.48M
55% more repeat investments, than reductions
Existing positions increased: 51 | Existing positions reduced: 33
18% more capital invested
Capital invested by funds: $484M → $571M (+$87.1M)
0% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 20
1% less funds holding
Funds holding: 132 → 131 (-1)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$27.6M |
| 2 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
+$19.6M |
| 3 |
OWP
Obermeyer Wealth Partners
Aspen,
Colorado
|
+$18.7M |
| 4 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
+$15.3M |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$11.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VAM
Visium Asset Management
New York
|
-$31M |
| 2 |
IGM
Incline Global Management
New York
|
-$12.1M |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
-$6.86M |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$6.68M |
| 5 |
PIP
Permian Investment Partners
Dallas,
Texas
|
-$6.02M |
AMRI Hedge Fund Activity: Q1 2015 in Review
131 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Albany Molecular Research Inc (AMRI) for Q1 2015, worth a combined $571M — up 18% from $484M a quarter earlier.
Fund positioning in AMRI was balanced in Q1 2015: 20 funds opened new positions, 20 closed out, 51 added to existing stakes and 33 trimmed.
The largest buyer was Goldman Sachs, adding an estimated $27.6M. The largest seller was Visium Asset Management, cutting an estimated $31M.
- 131 institutional investors held Albany Molecular Research Inc (AMRI) as of Q1 2015, down from 132 in Q4 2014.
- Funds reported $571M of Albany Molecular Research Inc stock for Q1 2015, up 18% quarter-over-quarter.
- 20 funds opened new Albany Molecular Research Inc positions in Q1 2015 and 20 closed out, a net change of 0 holders.
- The largest Albany Molecular Research Inc buyer in Q1 2015 was Goldman Sachs, an estimated $27.6M added.
- The largest Albany Molecular Research Inc seller in Q1 2015 was Visium Asset Management, an estimated $31M sold.
Based on aggregated 13F filings for Q1 2015.